drugset

drugset / Trial / NCT02161107

Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma

NCT02161107 ↗

Phase 2 Completed 54 enrolled Circassia Limited Adiga Life Sciences, Inc. · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether it is safe to administer Grass-SPIRE to subjects suffering from both grass allergy and asthma

Timeline

Start: 2014-04
Primary completion: 2015-03
Completion: 2015-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Grass-SPIRE	Unknown	—	Other

Indications